Literature DB >> 22833001

Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age.

Carla S Fisher1, Tonya Martin-Dunlap, Megan Baker Ruppel, Feng Gao, Jordan Atkins, Julie A Margenthaler.   

Abstract

INTRODUCTION: Recent studies have reported increases in the rate of mastectomy and contralateral prophylactic mastectomy (CPM). We hypothesized that there would be different reasons for choosing mastectomy for women aged <50 compared with those aged ≥50 years.
METHODS: A questionnaire was administered to 332 patients who underwent unilateral or bilateral mastectomy for breast cancer from 2006 to 2010. The survey queried on demographics, surgical choices, and rationale for those choices. A retrospective chart review was performed to determine tumor characteristics. Responses and clinical characteristics were described by contingency tables and compared using Fisher exact test or χ(2) test, as appropriate.
RESULTS: Of 332 patients surveyed, 310 were evaluable. Median age was 55 years, including 88 patients <50 (28 %) and 222 patients ≥50 (72 %) at time of diagnosis. Forty-four percent of women <50 and 41 % of women ≥50 were given the option of breast conservation and chose mastectomy (p > 0.63). The two groups did not differ in their reason for choosing mastectomy, with lower recurrence risk and improved survival cited as the two most common reasons. Younger patients were more likely to undergo reconstruction and CPM (p < 0.0001) as well as have estrogen receptor-negative tumors, undergo neoadjuvant chemotherapy, and have higher magnetic resonance imaging utilization (p < 0.05).
CONCLUSIONS: Choosing mastectomy and the reasons for doing so were the same for women aged <50 and ≥50 years. Prospective studies are needed to determine whether patient education regarding perceived versus actual recurrence risk and survival would alter this decision-making process.

Entities:  

Mesh:

Year:  2012        PMID: 22833001     DOI: 10.1245/s10434-012-2525-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  38 in total

1.  The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.

Authors:  Francesca Tamburelli; Riccardo Ponzone
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

Review 2.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

3.  Assessing the relationship between fear of cancer recurrence and health care utilization in early-stage breast cancer survivors.

Authors:  Amy K Otto; Emily C Soriano; Scott D Siegel; Stefanie T LoSavio; Jean-Philippe Laurenceau
Journal:  J Cancer Surviv       Date:  2018-10-19       Impact factor: 4.442

4.  Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study.

Authors:  Heather Spencer Feigelson; Ted A James; Richard M Single; Adedayo A Onitilo; Erin J Aiello Bowles; Tom Barney; Jordan E Bakerman; Laurence E McCahill
Journal:  J Am Coll Surg       Date:  2013-03-13       Impact factor: 6.113

5.  Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast Cancer.

Authors:  Shoshana M Rosenberg; Mary L Greaney; Andrea F Patenaude; Ann H Partridge
Journal:  J Adolesc Young Adult Oncol       Date:  2019-04-03       Impact factor: 2.223

6.  Surgical treatment choices for breast cancer in Newfoundland and Labrador: a retrospective cohort study.

Authors:  Farah McCrate; Elizabeth Dicks; Erin Powell; Joanne Chafe; Rebecca Roome; Charlene Simmonds; Holly Etchegary
Journal:  Can J Surg       Date:  2018-12-01       Impact factor: 2.089

7.  Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study.

Authors:  Andrea L Pusic; Evan Matros; Neil Fine; Edward Buchel; Gayle M Gordillo; Jennifer B Hamill; Hyungjin M Kim; Ji Qi; Claudia Albornoz; Anne F Klassen; Edwin G Wilkins
Journal:  J Clin Oncol       Date:  2017-03-27       Impact factor: 44.544

8.  Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study.

Authors:  L Findlay-Shirras; I Lima; G Smith; M Clemons; A Arnaout
Journal:  Breast Cancer Res Treat       Date:  2020-10-30       Impact factor: 4.872

9.  Factors associated with patients in the Scottish Highlands who chose mastectomy when suitable for breast conservation.

Authors:  Rosalyn Shearer; Majid Rashid; Gill Hubbard; Nick Abbott; Ian Daltrey; Russell Mullen
Journal:  Gland Surg       Date:  2016-08

Review 10.  Breast cancer therapy-associated cardiovascular disease.

Authors:  Timothy M Zagar; Daniela M Cardinale; Lawrence B Marks
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.